 |
|
 |
OFFICERS & DIRECTORS
ALDA Pharmaceuticals Corp. has brought together an experienced team with the required experience to build a pharmaceutical products business.
Management
Directors
- Dr. Terrance G. Owen CEO, President and Director
- Peter Chen CFO, Director and Secretary
- Dr. Linda Allison, Director
- Dr. Ronald Zokol, Director
- Eugene Hodgson, Director
- Dr. William McCoy, Director
Professional Advisors
In addition to the corporate management team, the following business advisors are active in providing professional services to the company:
- Getz Prince Wells: Legal Counsel and Registered Office
- Stanislaw Ashbaugh: US Legal Counsel
- Computershare Trust Company of Canada: Transfer Agent
- HLB Cinnamon Jang Willoughby & Company, Charted Accountants: Auditors
Dr. Terrance G. Owen BSc, MSc, MBA, PhD
CEO, President and Director
Dr. Owen obtained a Bachelor of Science (with honours) in Biology from the University of Victoria in 1968, a Masters degree in Biology from the University of New Brunswick in 1970, a Ph.D. in Zoology from the University of British Columbia in 1974 and a Masters in Business Administration from Simon Fraser University, British Columbia in 1991. From December, 1980, until April, 2002, Dr. Owen was the President of Helix Biotech, a biotechnology laboratory providing DNA identity testing services for paternity, immigration and forensic cases. He founded Duft Biotech Capital Ltd. in May, 2000 as a Capital Pool Company. In November, 2003, Duft acquired the assets of Dr. Shapiro's private company and was renamed ALDA Pharmaceuticals Corp. Dr. Owen's previous experience with public companies includes: President and a Director of Helix BioPharma Corp. from July 1995 to June 1998, International Helix Biotechnologies Inc. from October 1993 to June 1995 and Helix Biotech Corporation from September 1987 to October 1993.
Peter Chen
CFO, Director and Secretary
Mr. Chen obtained a diploma in Accounting from Douglas College in 1993. From November 2000, to October 2003, Mr. Chen was the Chief Financial Officer of Prospect Point Exploration & Management Services Ltd., a private company that provides mineral exploration consulting services. He was the President of Canadian Mineral Exploration Managing Consultants Inc., a private company that provides mineral exploration services to publicly listed companies that have projects in Africa and South East Asia, from January 1997 to January 2000 and Chief Financial Officer from February 1994 to January 2000. Mr. Chen is currently a director of the Douglas College Foundation. Mr. Chen is a founding shareholder and director of Duft Biotech Capital which was created in May, 2000.
Dr. Linda Allison BSc, MSc, DIC, PhD
Director
Dr. Allison received a BSc (Honours) from Simon Fraser University in 1969, a MSc from the University of London, United Kingdom and a DIC from the Imperial College of Science and Technology in London, United Kingdom in 1972. She received her PhD from Simon Fraser University in British Columbia, Canada in 1978 based on research in the areas of neurophysiology, molecular biology and biophysics. She is the founder and President of Snowdon & Associates Management Consultants Ltd., a professional management consulting company that has provided services to pharmaceutical biotechnology, medical device and high technology companies for over 20 years. Since 1999, Dr. Allison has been an advisor to ALDA on the development of the Company's strategic business plan and its corporate financing activities. In addition, she spent six years in the corporate finance departments of investment banking and brokerage firms, during which time she assisted the financing of biomedical and high technology companies in both North America and Europe. Dr. Allison was appointed as CEO and a Director of MDX Medical a biomedical company that develops medical imaging technologies for the improved diagnosis and treatment of cancer, in May, 2003 and a Director of Duft Biotech Capital in June, 2003.
Dr. Ronald Zokol DMD
Director
Dr. Zokol graduated from the Faculty of Dentistry at the University of British Columbia in 1974 and has been practicing dentistry for the last 26 years. He is the director of the Pacific Institute for Implant Dentistry and a Diplomat of the American Board of Oral Implantology, lecturing internationally in the fields of implant surgery and prosthodontics. In 1986, Dr. Zokol was elected President of the Vancouver and District Dental Society. Currently he also teaches advanced reconstructive dentistry. Dr. Zokol became a Director in November 2003.
Eugene Hodgson
Director
Mr. Hodgson is the president of Seeds Capital Inc., and E.A. Hodgson and Associates Inc. He currently serves as both CFO and Director of Sea Breeze Power Inc. and is a Director and co-founder of the "Families for School Seismic Safety" in BC. Mr. Hodgson is a former Director of the Vancouver Board of Trade and Treasurer of the Liberal Party of Canada.
Dr. William McCoy, PhD Microbiology
Director
Dr. McCoy is Chief of Technology Officer for Phigenics, LLC, a life sciences technology company based in Chicago, Illinois. He serves on the World Health Organization (WHO) committee. Dr. McCoy received the Intellectual Property Law Association "2001 Inventor of the Year" award and has been commissioned to write a book for The International Water Association.
Scientific Advisory Board
Dr. Brian Conway - MD, FRCPC
Dr. Conway graduated from McGill University medical school in 1982. In 1998, he received an Award of Excellence from the Canadian Hemophilia Society for his life-long work with HIV and other blood-borne infections. He is actively involved in the evaluation of new anti-HIV drugs and has been awarded a number of grants to study acute/early HIV infection and treatment of infections in intravenous drug users. Dr. Conway conducted the original tests on the effectiveness of T36® against HIV. He has a thorough understanding of protocols and requirements for product development.
Dr. Michael Wilby - BSc, DDS, Cert. Periodontology
Dr. Wilby is a graduate of McGill University in General Dentistry. He pursued his specialty training in Periodontology at the University of Oregon. He has established private practices in Vancouver B.C., Richmond B.C. and Whitehorse, Yukon Territories. Dr. Wilby provides specialty services in Periodontics and Dental Implants. He is a member of numerous dental organizations and has lectured in the Periodontology Department at the University of British Columbia. Dr. Wilby is a director and founder of ALDA Pharmaceuticals, with a strong foundation in infection control.
Dr. Allan H. Shapiro B.Sc., D.D.S., F.A.G.D.
Dr. Allan H. Shapiro is the Manager of Business Development & Regulatory Affairs of ALDA Pharmaceuticals Corp., a publicly traded company on the TSX-V, under APH and the OTCBB under APCSF. Dr. Shapiro founded ALDA Pharmaceuticals Inc., a private company, in February, 1996 and is the developer of ALDA's infection control technology and products. Dr. Shapiro is responsible for the overall business development of ALDA, overseeing the regulatory matters and the development of future products. He received a B.Sc. from Sir George Williams University, Montreal, in 1968 and a Doctorate in Dental Surgery from McGill University, Montreal, in 1972. In 1979, he was awarded a Fellowship in the US Academy of General Dentistry and then practiced Dentistry for over twenty years. Dr. Shapiro is a member of the American Industrial Hygiene Association (AIHA), The Ontario Dental Association (ODA), The Canadian Dental Association (CDA), The Royal College of Dental Surgeons of Ontario (RCDSO), has co-authored scientific research papers on infection control and has written several risk management manuals for the first responders.